We are live on ! Find out more
LBA

Letko, Brosseau & Associates Portfolio holdings

AUM $6.77B
1-Year Est. Return 38.11%
This Fund
S&P 500
This Quarter Est. Return
-1.28%
1 Year Est. Return
+38.11%
3 Year Est. Return
+83.35%
5 Year Est. Return
+109.01%
10 Year Est. Return
+317.99%
AUM
$5.1B
AUM Growth
-$265M
Cap. Flow
-$139M
Cap. Flow %
-2.71%
Top 10 Hldgs %
33.26%
Holding
99
New
5
Increased
24
Reduced
50
Closed
1

Top Sells

Rank Stock Value
1
CLS icon
Celestica
CLS
+$126M
2
VMW
VMware, Inc
VMW
+$44.6M
3
MFC icon
Manulife Financial
MFC
+$4.47M
4
SBS icon
Sabesp
SBS
+$4.36M
5
CX icon
Cemex
CX
+$4.16M

Sector Composition

Rank Sector Weight
1 Financials 29.53%
2 Communication Services 16.63%
3 Energy 11.73%
4 Materials 11.71%
5 Healthcare 8.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAE icon
26
CAE Inc
CAE
$7.83B
$72.5M 1.42%
3,089,604
-59,440
-2% -$1.37M
PFE icon
27
Pfizer
PFE
$158B
$70M 1.37%
2,109,235
+33,990
+2% +$1.2M
C icon
28
Citigroup
C
$228B
$66M 1.29%
1,604,925
+33,400
+2% +$1.47M
SWKS icon
29
Skyworks Solutions
SWKS
$11.9B
$65.4M 1.28%
662,857
+91,900
+16% +$9.77M
T icon
30
AT&T
T
$182B
$65.3M 1.28%
4,346,582
+43,300
+1% +$635K
STT icon
31
State Street
STT
$51.7B
$61.2M 1.2%
913,715
+4,870
+0.5% +$343K
WMT icon
32
Walmart Inc
WMT
$865B
$60.2M 1.18%
1,129,455
-15,156
-1% -$807K
SHEL icon
33
Shell
SHEL
$276B
$59.5M 1.16%
923,432
-13,682
-1% -$852K
BERY
34
DELISTED
Berry Global Group, Inc.
BERY
$59.2M 1.16%
1,040,823
-6,321
-0.6% -$372K
EMN icon
35
Eastman Chemical
EMN
$7.66B
$59M 1.16%
769,274
+6,725
+0.9% +$558K
COP icon
36
ConocoPhillips
COP
$164B
$54.4M 1.07%
454,405
-7,627
-2% -$885K
CVS icon
37
CVS Health
CVS
$122B
$53.8M 1.05%
771,110
+254,900
+49% +$18.1M
VZ icon
38
Verizon
VZ
$213B
$51.3M 1.01%
1,583,905
+20,153
+1% +$681K
ABBV icon
39
AbbVie
ABBV
$463B
$50.8M 1%
340,744
-2,540
-0.7% -$373K
ELP
40
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
$48.6M 0.95%
6,932,494
-535,469
-7% -$3.7M
TFC icon
41
Truist Financial
TFC
$61.2B
$48.1M 0.94%
1,681,256
+89,465
+6% +$2.75M
CRUS icon
42
Cirrus Logic
CRUS
$5.83B
$45.4M 0.89%
614,374
+16,935
+3% +$1.32M
WFC icon
43
Wells Fargo
WFC
$268B
$45.3M 0.89%
1,107,499
-1,085
-0.1% -$46.8K
ORCL icon
44
Oracle
ORCL
$417B
$44.5M 0.87%
420,137
-8,285
-2% -$959K
GSK icon
45
GSK
GSK
$100B
$43.4M 0.85%
1,197,968
+10,515
+0.9% +$373K
HES
46
DELISTED
Hess
HES
$41.9M 0.82%
273,897
-4,026
-1% -$606K
QSR icon
47
Restaurant Brands International
QSR
$27.5B
$40.7M 0.8%
608,299
-33,080
-5% -$2.38M
EFXT
48
Enerflex
EFXT
$2.71B
$39.6M 0.78%
6,863,456
-46,355
-0.7% -$311K
FDX icon
49
FedEx
FDX
$74B
$39.5M 0.77%
148,955
-3,270
-2% -$850K
SKX
50
DELISTED
Skechers
SKX
$38.7M 0.76%
791,555
+620
+0.1% +$31.7K

Similar funds

Letko, Brosseau & Associates's Q3 2023 Portfolio in Review

As of Q3 2023, Letko, Brosseau & Associates held 99 positions worth $5.1B, down 4.9% from $5.37B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Letko, Brosseau & Associates's Q3 2023 filing shows 5 new, 24 increased, 50 reduced and 1 closed positions. Its largest new stake was Fidelity National Information Services: 561,000 shares worth $31M. The largest sale was Celestica, an estimated $126M.

By sector, the portfolio is most concentrated in Financials at 30% of assets, down from 30% a quarter earlier, followed by Communication Services and Energy.

  • Letko, Brosseau & Associates's largest Q3 2023 buy was Fidelity National Information Services: 561,000 shares worth $31M.
  • Letko, Brosseau & Associates added most to CVS Health in Q3 2023, an estimated $18.1M increase.
  • Letko, Brosseau & Associates's biggest Q3 2023 reduction was Celestica, cutting an estimated $126M.
  • Letko, Brosseau & Associates fully exited VMware, Inc in Q3 2023, selling an estimated $44.6M.
  • Letko, Brosseau & Associates's ten largest holdings make up 33% of its $5.1B portfolio in Q3 2023.
  • Letko, Brosseau & Associates opened 5 new positions and closed 1 in Q3 2023.
  • Letko, Brosseau & Associates's portfolio value fell 4.9% quarter-over-quarter to $5.1B.

Based on Letko, Brosseau & Associates's 13F filing for Q3 2023, filed 9 Nov 2023.